Recursion Pharmaceuticals (RXRX) Cost of Revenue (2022 - 2026)
Recursion Pharmaceuticals' Cost of Revenue was $11.49 million in Q2 2026, down 43.0% from $20.16 million a year earlier and down 8.0% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Cost of Revenue (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Recursion Pharmaceuticals' Cost of Revenue was $52.94 million through Jun 30, 2026, down 20.8% year-over-year; for FY2025, it came in at $70.95 million, up 56.8% from FY2024.
- Cost of Revenue shows a three-year compound annual growth rate of 13.7% (FY2022 to FY2025).
- In earlier years, Cost of Revenue was $45.24 million in FY2024 (+6.2%), $42.59 million in FY2023 (-11.8%) and $48.28 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Cost of Revenue since Q2 2024.
- Compared with a year earlier, Cost of Revenue was higher in six of the last eight quarters, with growth averaging 25.3%.
- The best year-over-year quarter for Cost of Revenue over five years was Q2 2025 (growth of 119.2%); the worst was Q2 2026 (a decline of 43.0%).
- Per Business Quant data, RXRX's Cost of Revenue in the three quarters before Q2 2026 was $12.49 million (Q1 2026), $14.28 million (Q4 2025) and $14.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Recursion Pharmaceuticals | 2.20 Bn | -402.71 Mn | -3.82 Mn | 11.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.49 Mn |
| Mar 31, 2026 | 12.49 Mn |
| Dec 31, 2025 | 14.28 Mn |
| Sep 30, 2025 | 14.69 Mn |
| Jun 30, 2025 | 20.16 Mn |
| Mar 31, 2025 | 21.83 Mn |
| Dec 31, 2024 | 12.79 Mn |
| Sep 30, 2024 | 12.08 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Mar 31, 2024 | 11.17 Mn |
| Dec 31, 2023 | 9.88 Mn |
| Sep 30, 2023 | 10.88 Mn |
| Jun 30, 2023 | 9.38 Mn |
| Mar 31, 2023 | 12.45 Mn |
| Dec 31, 2022 | 10.84 Mn |
| Sep 30, 2022 | 15.41 Mn |
| Jun 30, 2022 | 14.23 Mn |
| Mar 31, 2022 | 7.80 Mn |
API Access
Recursion Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();